These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5529422)

  • 1. [Mechanism of action of 6-mercaptopurine and thioinosine, and clinical effects of the agents].
    Nakamura T
    Naika Hokan; 1970 Oct; 17(10):375-84. PubMed ID: 5529422
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formate activation and de novo synthesis of purine nucleotides in leukemia cells and its therapeutic modification by 6-mercaptopurine].
    Wilmanns W
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 147(2):154-72. PubMed ID: 5245869
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with analogues of purine nucleosides.
    LePage GA
    Natl Cancer Inst Monogr; 1971 Dec; 34():184-7. PubMed ID: 5140862
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary clinical trial with a purine analogue butocine.
    Cerný V
    Neoplasma; 1971; 18(5):489-92. PubMed ID: 5287027
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside.
    Paterson AR; Wang MC
    Cancer Res; 1970 Sep; 30(9):2379-87. PubMed ID: 4319905
    [No Abstract]   [Full Text] [Related]  

  • 6. Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.
    Bennett LL; Allan PW
    Cancer Res; 1971 Feb; 31(2):152-8. PubMed ID: 5545266
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic effect of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside on the levels of adenine nucleotides of Sarcoma 180 cells.
    Scholar EM; Brown PR; Parks RE
    Cancer Res; 1972 Feb; 32(2):259-69. PubMed ID: 5058187
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nucleic acid metabolism of leukemic leukocytes. 2. The effect of 6-mercaptopurine on nucleic acid metabolism of leukemic leukocytes].
    Kano A
    Naika Hokan; 1968 Aug; 15(8):245-53. PubMed ID: 5751146
    [No Abstract]   [Full Text] [Related]  

  • 9. [Targets of antileukemia agents: molecular mechanisms of mercaptopurine action].
    Krynetskaia NF; Krynetskiĭ EIu
    Mol Biol (Mosk); 2000; 34(6):1046-53. PubMed ID: 11186004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment and prognosis of acute leukemia].
    Kimura K; Konda C; Shimoyama M
    Naika; 1965 Oct; 16(4):645-53. PubMed ID: 5885631
    [No Abstract]   [Full Text] [Related]  

  • 11. Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine.
    Chao DL; Kimball AP
    Cancer Res; 1972 Aug; 32(8):1721-4. PubMed ID: 5044132
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effects of the arabinosides of 6-mercaptopurine and cytosine on purine and pyrimidine metabolism.
    Kimball AP; Bowman B; Bush PS; Herriot J; LePage GA
    Cancer Res; 1966 Jul; 26(7):1337-43. PubMed ID: 5911573
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromatographic studies of purine metabolism. VI. Inhibition of inosine phosphorylase by 6-mercaptopurine.
    Tomisek AJ; Hoskins AP; Reid MR
    Cancer Res; 1965 Dec; 25(11):1925-32. PubMed ID: 5323535
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sulfur containing purine nucleosides on immunological reaction in mice. I. Immunosuppressive effect of several alkylthio, aralkylthio and thiocyanatopurines and their ribonucleosides.
    Sekine T; Arai Y; Saneyoshi M
    Jpn J Exp Med; 1973 Oct; 43(5):369-75. PubMed ID: 4544070
    [No Abstract]   [Full Text] [Related]  

  • 15. COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER.
    REGELSON W; HOLLAND JF; FREI E; GOLD GL; HALL T; KRANT M; MILLER SO
    Cancer Chemother Rep; 1964 Mar; 36():41-8. PubMed ID: 14152273
    [No Abstract]   [Full Text] [Related]  

  • 16. SUMMARY OF INFORMAL DISCUSSION ON THE ROLE OF PURINE ANTAGONISTS.
    HITCHINGS GH
    Cancer Res; 1963 Sep; 23():1218-25. PubMed ID: 14070378
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanism of action of anti-leukemia agents and adverse effects].
    Nakamura T; Ueda T
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1033-9. PubMed ID: 1402252
    [No Abstract]   [Full Text] [Related]  

  • 18. Purine ribonucleoside kinase activity and resistance to some analogs of adenosine.
    Bennett LL; Schnebli HP; Vail MH; Allan PW; Montgomery JA
    Mol Pharmacol; 1966 Sep; 2(5):432-43. PubMed ID: 5970690
    [No Abstract]   [Full Text] [Related]  

  • 19. THE PRIMARY SITE OF INHIBITION BY 6-MERCAPTOPURINE ON THE PURINE BIOSYNTHETIC PATHWAY IN SOME TUMORS IN VIVO.
    BENNETT LL; SIMPSON L; GOLDEN J; BARKER TL
    Cancer Res; 1963 Oct; 23():1574-80. PubMed ID: 14072699
    [No Abstract]   [Full Text] [Related]  

  • 20. Feedback inhibition of purine biosynthesis in adenocarcinoma 755 and sarcoma 180 cells in culture.
    Dixon GJ; Dulmadge EA; Brockman RW; Shaddix SC
    J Natl Cancer Inst; 1970 Oct; 45(4):681-5. PubMed ID: 5535124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.